Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02247544
What this trial is testing

Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma

Who this might be right for
LiposarcomaLeiomyosarcoma
Italian Sarcoma Group 105
Not applicableStudy completedNCT04690231
What this trial is testing

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, DrugSecondary Resistance
Peking University People's Hospital 79
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551430
What this trial is testing

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic Soft-tissue Sarcoma
Washington University School of Medicine 105
Testing effectiveness (Phase 2)Study completedNCT04554836
What this trial is testing

MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the Rectum
TheraOp 6
Testing effectiveness (Phase 2)Study completedNCT02406781
What this trial is testing

Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

Who this might be right for
Sarcoma
Institut Bergonié 129
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)UnknownNCT04065152
What this trial is testing

Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
Assistance Publique - Hôpitaux de Paris 20
Not applicableStudy completedNCT05801887
What this trial is testing

Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro Study

Who this might be right for
Osteosarcoma
Krishnadevaraya College of Dental Sciences & Hospital 20
Early research (Phase 1)Ended earlyNCT00002863
What this trial is testing

Cryosurgery in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University of Southern California 19
Early research (Phase 1)Ended earlyNCT00005655
What this trial is testing

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

Who this might be right for
Kidney NeoplasmLung NeoplasmSarcoma+1 more
National Cancer Institute (NCI) 39
Early research (Phase 1)Ended earlyNCT05130255
What this trial is testing

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Who this might be right for
SCLCMalignant MelanomaSarcoma+1 more
Y-mAbs Therapeutics 23
Early research (Phase 1)Temporarily pausedNCT00077493
What this trial is testing

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
MedImmune LLC 95
Testing effectiveness (Phase 2)UnknownNCT06384248
What this trial is testing

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Who this might be right for
Unresectable or Metastatic Sarcoma
Letolab 30
Early research (Phase 1)Looking for participantsNCT06644755
What this trial is testing

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorsSarcoma
Daiichi Sankyo 150
Testing effectiveness (Phase 2)Study completedNCT04807816
What this trial is testing

Targeting ATR in Soft-tissue Sarcomas

Who this might be right for
Leiomyosarcoma, Adult
Institut Bergonié 58
Not applicableLooking for participantsNCT06751355
What this trial is testing

Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

Who this might be right for
Kaposi Sarcoma
Washington University School of Medicine 30
Early research (Phase 1)Study completedNCT00054236
What this trial is testing

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)UnknownNCT02052128
What this trial is testing

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Who this might be right for
Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
Arno Therapeutics 60
Next Page